← Back to headlines
Ionis Pharmaceuticals Extends Losses as Roche Scraps Studies
Ionis Pharmaceuticals experienced extended losses after Roche decided to terminate two partnered studies, impacting the biotech company's outlook.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
